Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
SparingVision
This is an open, longitudinal, prospective, multicentric study to describe the disease progression in patients with retinitis pigmentosa due to mutation in genes with selective expression in rods: rhodopsin (RHO), phosphodiesterase 6a (PDE6a) or phosphodiesterase 6b (PDE6b).RHO,PDE6A or PDE6B mutation.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
RP with mutations affecting the RHO, PDE6A and PDE6B genes
Visual acuity ≥ 20/200 for at least one eye at inclusion visit
Binocular Visual field diameter ≥ 5° as measured on the Goldmann III-4e isopter at inclusion visit
Patients having signed the informed consent form
Sufficient knowledge of the local language to ensure understanding of the tasks to be performed and the instructions received
Patient affiliated to a Health Security System if they are included in a clinical site based in France (per law)
You may not be if
Patients with any other gene mutation known to be involved in RP
Patients with other ocular disorder likely to impact the retinal function
Pregnant or breastfeeding women
Clareo Health | Prospective Natural History Study of Retinitis Pigmentosa
